Treatment Summary and Care Plan for Breast Cancer Survivors: acceptability and feasibility study.
Maria das Graças Silva Matsubara, Fabiana Baroni Alves Makdissi, Simone Elias and 3 others
PMID 40736105WHAT IT FOUND
Most breast cancer survivors accepted a post-treatment care plan booklet, with 81.6% favorable responses.
Nurses found delivering it feasible, with 84.2% favorable responses. The study did not test whether the plan improved health outcomes.
Key findings
01Fifty survivors were retained across three data collection times, with 98.0% retention and 99.3% adherence.
02Survivor acceptability was 81.6% overall: suitability 93.3%, convenience 85.0%, effectiveness 73.5%, and adherence 74.0%.
03Open comments valued the plan as a guide and learning tool, but raised discomfort with the term 'survivor', excess length, and requests for personalization.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
Only acceptability and feasibility were measured; the study did not test whether the care plan improved health, quality of life, or self-management. All survivors were women with breast cancer treated at one accredited cancer centre in São Paulo, and all were linked to the Supplementary Health System, so results may not apply to public settings. The survivor group had high education and class A or B, which the authors say differs from the national scenario. Only 10 nurses were assessed, and the authors say a larger professional sample is needed. Qualitative comments were provided by 39 of 50 survivors and 7 of 10 nurses, so they do not reflect all participants. One of 51 consenting survivors was not retained, and some acceptability and feasibility dimensions were below the pre-set 80% threshold.
Declared interests
Funded in part by CAPES and supported by CNPq.
The easy way to misread this
Do not read the high acceptability and feasibility rates as proof that the care plan improves breast cancer survivors' quality of life, reduces late effects, or changes clinical outcomes. This study measured only whether survivors and nurses accepted and could implement the plan, and it was done in one accredited centre with a small nurse sample and a mostly high-income survivor group.